Biotech · Private company · Elm Grove, WI, US

Reneurogen, LLC

Track this companyFree. Adds Reneurogen, LLC to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards4

KYC, an inhibitor of sickle cell disease's vicious cycle in vaso-occlusive crisis and painFiscal year 2026 · $967KNIH RePORTER 5R44HL178153-02 · fetched Nov 12, 2026
KYC, an inhibitor of sickle cell disease's vicious cycle in vaso-occlusive crisis and painFiscal year 2025 · $1MNIH RePORTER 1R44HL178153-01 · fetched Nov 12, 2026
Development of a systems pharmacology agent for treatment of bronchopulmonary dysplasiaFiscal year 2025 · $50KNIH RePORTER 3R44HL166018-02S1 · fetched Nov 12, 2026
Development of a systems pharmacology agent for treatment of bronchopulmonary dysplasiaFiscal year 2024 · $1.9MNIH RePORTER 5R44HL166018-02 · fetched Nov 12, 2026